This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.a.. Active years: 2008.
Company Filing History:
Years Active: 2008
Title: Anna Floriana Sciarroni: Innovator in Diabetes Treatment
Introduction
Anna Floriana Sciarroni is a notable inventor based in Pomezia, Italy. She has made significant contributions to the field of medicine, particularly in the treatment of diabetes. Her innovative work focuses on the development of compounds that can aid in managing blood sugar levels and lipid profiles.
Latest Patents
Anna holds a patent for the "Use of α-phenylthiocarboxylic and α-phenyloxycarboxylic acids with serum-glucose-lowering and serum-lipid-lowering activity." This patent describes the use of derivatives of these acids for preparing a medicine aimed at the prophylaxis and treatment of diabetes, especially type 2 diabetes, along with its complications and various forms of insulin resistance and hyperlipidaemias. She has 1 patent to her name.
Career Highlights
Anna is associated with Sigma-Tau Industrie Farmaceutiche Riunite S.p.a., where she has been instrumental in advancing pharmaceutical research. Her work has been pivotal in developing new therapeutic strategies for diabetes management.
Collaborations
Throughout her career, Anna has collaborated with esteemed colleagues, including Emanuela Tassoni and Maria Ornella Tinti. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Anna Floriana Sciarroni's contributions to diabetes treatment through her innovative patents and collaborations highlight her role as a leading inventor in the pharmaceutical industry. Her work continues to impact the lives of many individuals affected by diabetes.